Maternal Exposure to Amoxicillin and the Risk of Oral Clefts

被引:46
作者
Lin, Kueiyu Joshua [2 ]
Mitchell, Allen A. [1 ]
Yau, Wai-Ping [2 ,3 ]
Louik, Carol [1 ]
Hernandez-Diaz, Sonia [2 ]
机构
[1] Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[3] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore
关键词
OROFACIAL CLEFTS; MEDICATION USE; PREGNANCY; SMOKING;
D O I
10.1097/EDE.0b013e318258cb05
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Prior studies have suggested an increased risk of oral clefts after exposure to amoxicillin in early pregnancy, but findings have been inconsistent. Methods: Among participants in the Slone Epidemiology Center Birth Defects Study from 1994 to 2008, we identified 877 infants with cleft lip with/without cleft palate and 471 with cleft palate alone. Controls included 6952 nonmalformed infants. Mothers were interviewed about demographic, reproductive and medical factors, and details of medication use. We estimated odds ratios (ORs) and 95% confidence intervals (CIs) associated with use of amoxicillin in the first trimester using conditional logistic regression and adjusting for known risk factors for oral clefts, as well as for infections, fever, and concomitant treatments. Results: In the control group, 2.1% of women had used amoxicillin in the first trimester. Maternal use of amoxicillin was associated with an increased risk of cleft lip with/without cleft palate (adjusted OR = 2.0 [95% confidence interval = 1.0-4.1]), with an OR of 4.3 (1.4-13.0) for third-gestational-month use. Risks were not elevated for use of other penicillins or cephalosporins. For cleft palate, the OR for first-trimester amoxicillin was 1.0 (0.4-2.3) with an OR of 7.1 (1.4-36) for third-gestational month use. Conclusions: Amoxicillin use in early pregnancy may be associated with an increased risk of oral clefts.
引用
收藏
页码:699 / 705
页数:7
相关论文
共 20 条
[1]  
Briggs G.G., 2005, DRUGS PREGNANCY LACT, V5th
[2]   Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations [J].
Cooper, William O. ;
Hernandez-Diaz, Sonia ;
Arbogast, Patrick G. ;
Dudley, Judith A. ;
Dyer, Shannon M. ;
Gideon, Patricia S. ;
Hall, Kathleen S. ;
Kaltenbach, Lisa A. ;
Ray, Wayne A. .
PAEDIATRIC AND PERINATAL EPIDEMIOLOGY, 2009, 23 (01) :18-28
[3]   Antibacterial Medication Use During Pregnancy and Risk of Birth Defects National Birth Defects Prevention Study [J].
Crider, Krista S. ;
Cleves, Mario A. ;
Reefhuis, Jennita ;
Berry, Robert J. ;
Hobbs, Charlotte A. ;
Hu, Dale J. .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2009, 163 (11) :978-985
[4]   Augmentin treatment during pregnancy and the prevalence of congenital abnormalities - A population-based case-control teratologic study [J].
Czeizel, AE ;
Rockenbauer, M ;
Sorensen, HT ;
Olsen, J .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2001, 97 (02) :188-192
[5]   A population-based case-control teratologic study of ampicillin treatment during pregnancy [J].
Czeizel, AE ;
Rockenbauer, M ;
Sorensen, HT ;
Olsen, J .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2001, 185 (01) :140-147
[6]   Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial clefts [J].
Honein, Margaret A. ;
Rasmussen, Sonia A. ;
Reefhuis, Jennita ;
Romitti, Paul A. ;
Lammer, Edward J. ;
Sun, Lixian ;
Correa, Adolfo .
EPIDEMIOLOGY, 2007, 18 (02) :226-233
[7]   A population-based study of maternal use of amoxicillin and pregnancy outcome in Denmark [J].
Jepsen, P ;
Skriver, MV ;
Floyd, A ;
Lipworth, L ;
Schonheyder, HC ;
Sorensen, HT .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 55 (02) :216-221
[8]  
Keith L, 2008, DEV HUMAN CLIN ORIEN
[9]   Maternal smoking and the risk of orofacial clefts - Susceptibility with NAT1 and NAT2 polymorphisms [J].
Lammer, EJ ;
Shaw, GM ;
Iovannisci, DM ;
Van Waes, J ;
Finnell, RH .
EPIDEMIOLOGY, 2004, 15 (02) :150-156
[10]  
Little J, 2004, B WORLD HEALTH ORGAN, V82, P213